Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

22.15
+0.08000.36%
Volume:67.91K
Turnover:1.50M
Market Cap:383.22M
PE:-2.33
High:22.45
Open:21.68
Low:21.61
Close:22.07
Loading ...
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]